Procter & Gamble Stock Tumbles on Downgrade Amid Analyst Optimism
Procter & Gamble's stock price dropped slightly after a valuation downgrade from Argus Research, but analysts still see potential for growth. The company's shares were trading near $144 on August 12, 2026, down about 0.8 percent on the day.
The downgrade to Hold was based on concerns about the stock's current multiple, which stands at around 21 times forward earnings. However, this is an outlier among analysts' views, as 13 out of 24 analysts rate the stock as a Buy and only 11 as a Hold.
Despite the individual downgrade, Procter & Gamble remains a core holding in many defensive portfolios due to its stable blue-chip profile, dividend policy, and strong brand portfolio. The company's next regular quarterly dividend payment of $1.0885 per share is scheduled for August 17, 2026.
The stock's recent price action suggests that it is seen as fairly valued or modestly undervalued rather than deeply discounted. The average twelve-month price target among analysts stands at $161.52, implying a potential upside of around 11.24 percent.